# Shivani Garg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/shivani-garg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 597 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 13 |
| i10-index | 19 |
| Last Known Institution | University of Wisconsin–Madison |
| OpenAlex ID | https://openalex.org/A5048317345 |
| ORCID iD | 0000-0001-7272-2692 |
| Works | 69 |

## Researcher papers

- [2024 American College of Rheumatology (<scp>ACR</scp>) Guideline for the Screening, Treatment, and Management of Lupus Nephritis](https://scholariq.org/papers/2024-american-college-of-rheumatology-scp-acr-scp-guideline-for-the-screening-2/)
- [Clinical Significance of Monitoring Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta‐Analysis](https://scholariq.org/papers/clinical-significance-of-monitoring-hydroxychloroquine-levels-in-patients-with/)
- [2024 American College of Rheumatology (<scp>ACR</scp>) Guideline for the Screening, Treatment, and Management of Lupus Nephritis](https://scholariq.org/papers/2024-american-college-of-rheumatology-scp-acr-scp-guideline-for-the-screening/)
- [2025 American College of Rheumatology ( <scp>ACR</scp> ) Guideline for the Treatment of Systemic Lupus Erythematosus](https://scholariq.org/papers/2025-american-college-of-rheumatology-scp-acr-scp-guideline-for-the-treatment-of/)
- [Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and <scp>Meta‐Analysis</scp>](https://scholariq.org/papers/improvement-in-cutaneous-lupus-erythematosus-after-twenty-weeks-of-belimumab-use/)
- [Investigating lupus retention in care to inform interventions for disparities reduction: an observational cohort study](https://scholariq.org/papers/investigating-lupus-retention-in-care-to-inform-interventions-for-disparities/)
- [Reference Range of Hydroxychloroquine Blood Levels That Can Reduce Odds of Active Lupus and Prevent Flares](https://scholariq.org/papers/reference-range-of-hydroxychloroquine-blood-levels-that-can-reduce-odds-of/)
- [Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities](https://scholariq.org/papers/timing-and-predictors-of-incident-cardiovascular-disease-in-systemic-lupus/)
- [Multiplicative Impact of Adverse Social Determinants of Health on Outcomes in Lupus Nephritis: A Meta‐analysis and Systematic Review](https://scholariq.org/papers/multiplicative-impact-of-adverse-social-determinants-of-health-on-outcomes-in/)
- [One Quarter of Medicare Hospitalizations in Patients with Systemic Lupus Erythematosus Readmitted within Thirty Days](https://scholariq.org/papers/one-quarter-of-medicare-hospitalizations-in-patients-with-systemic-lupus/)
- [Multidisciplinary Lupus Nephritis Clinic Reduces Time to Renal Biopsy and Improves Care Quality](https://scholariq.org/papers/multidisciplinary-lupus-nephritis-clinic-reduces-time-to-renal-biopsy-and/)
- [High Burden of Premature Arteriosclerosis on Renal Biopsy Results in Incident Lupus Nephritis](https://scholariq.org/papers/high-burden-of-premature-arteriosclerosis-on-renal-biopsy-results-in-incident/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Drug-Induced Ocular Toxicity](https://scholariq.org/topics/drug-induced-ocular-toxicity/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Cytomegalovirus and herpesvirus research](https://scholariq.org/topics/cytomegalovirus-and-herpesvirus-research/)

## Researcher university

- [University of Wisconsin–Madison](https://scholariq.org/institutions/university-of-wisconsin-madison/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.